Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baby Barista was a private U.S. consumer health and infant nutrition company that developed an automated infant formula bottle maker designed to prepare warm, consistently mixed bottles in under 30 seconds. The company combined a countertop hardware device with compatible formula pouches, a mobile app for remote preparation and feeding tracking, and a subscription-style supply model. Its offering was aimed at simplifying formula feeding for parents and caregivers rather than developing therapeutics or traditional biopharmaceutical products. Although the website still describes the product and mission, third-party business databases indicate the company became out of business in October 2023. For biotech and pharma diligence purposes, Baby Barista is best categorized as a health-related consumer device and infant nutrition technology company, not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baby Barista.